Marco Valgimigli

Showing 1-20 of 54 articles

Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang C, Kogame N, Spitzer E, Buszman P, van Geuns R, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabaté M, Zmudka K, Rademaker-Havinga T, Tijssen J, Jüni P, Hamm C, Steg P, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys P

April 3, 2020 | 10.4244/EIJ-D-19-00699

Coronary interventions

Validation of Bleeding Risk Criteria (ARC-HBR) in Patients Undergoing Percutaneous Coronary Intervention and Comparison with Contemporary Bleeding Risk Scores

Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis G, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L

February 18, 2020 | 10.4244/EIJ-D-20-00052

Coronary interventions

Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang C, Kogame N, Spitzer E, Buszman P, van Geuns R, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabaté M, Zmudka K, Rademaker-Havinga T, Tijssen J, Jüni P, Hamm C, Steg G, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys P

December 17, 2019 | 10.4244/EIJ-D-19-00699

The SYNTAX score on its way out or … towards artificial intelligence: part II

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone GW, Onuma Y

October 25, 2019 | 10.4244/EIJ-D-19-00543B

The SYNTAX score on its way out or … towards artificial intelligence: part I

October 25, 2019 | 10.4244/EIJ-D-19-00543A

Coronary interventions

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H-P, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

September 10, 2019 | 10.4244/EIJ-D-19-00498

Coronary interventions

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabaté M, Iqbal J, Wykrzykowska J, Piek J, Spitzer E, Jüni P, Hamm C, Steg P, Valgimigli M, Vranckx P, Windecker S, Serruys P

August 9, 2019 | 10.4244/EIJ-D-19-00184

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial

Gargiulo G, Pasquetto G, Brugaletta S, Ferrari F, Casu G, Guiducci V, Dellavalle A, Liistro F, Mauro C, van't Hof A, Omerovic E, Curello S, de la Torre Hernandez J, De Servi S, Belloni F, Windecker S, Penzo C, Colombo A, da Costa B, Frigoli E, Palmieri C, Nazzaro M, Falcone C, Liso A, Vigna C, Abate F, Comeglio M, Diletti R, Gabrielli G, Di Lorenzo E, Mazzarotto P, Zimarino M, Moretti C, Valgimigli M

June 12, 2019 | 10.4244/EIJ-D-18-00247

Transradial left main PCI is safe and effective

Jolly S, Valgimigli M

November 20, 2018 | 10.4244/EIJV14I10A192

A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial

Iglesias JF, Mueller O, Zaugg S, Roffi M, Kurz D, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeckhout E, Jüni P, Windecker S, Pilgrim T

August 24, 2018 | 10.4244/EIJ-D-17-00734

Current use of intracoronary imaging in interventional practice – Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey

Koskinas K, Nakamura M, Räber L, Colleran R, Kadota K, Capodanno D, Wijns W, Akasaka T, Valgimigli M, Guagliumi G, Windecker S, Byrne R

July 20, 2018 | 10.4244/EIJY18M03_01

STEMI

Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial

Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Valgimigli M, Serruys P, Sabaté M

March 20, 2018 | 10.4244/EIJ-D-17-00608

Coronary interventions

State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation – past, present and future perspectives

Gargiulo G, Valgimigli M, Capodanno D, Bittl J

August 25, 2017 | 10.4244/EIJ-D-17-00468

Coronary interventions

Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial

Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys P, Sabaté M

August 4, 2017 | 10.4244/EIJ-D-16-00512

Coronary interventions

Will PIONEER AF-PCI change my practice?

Ukena C, Leonardi S, Palmerini T, Lansky A, Montalescot G, Valgimigli M

August 4, 2017 | 10.4244/EIJV13I5A95

Coronary interventions

Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial

Piccolo R, Magnani G, Ariotti S, Gargiulo G, Marino M, Santucci A, Franzone A, Tebaldi M, Heg D, Windecker S, Valgimigli M

May 15, 2017 | 10.4244/EIJ-D-16-00497

Interventions for valvular disease

Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation

Franzone A, O’Sullivan C, Stortecky S, Heg D, Lanz J, Vollenbroich R, Praz F, Piccolo R, Asami M, Roost E, Räber L, Valgimigli M, Windecker S, Pilgrim T

April 7, 2017 | 10.4244/EIJ-D-16-00790

Coronary interventions

A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis

Colombo A, Basavarajaiah S, Limbruno U, Picchi A, Lettieri C, Valgimigli M, Sciahbasi A, Prati F, Calabresi M, Pierucci D, Guglielmotti A

December 9, 2016

Coronary interventions

A tool for predicting the outcome of reperfusion in ST-elevation myocardial infarction using age, thrombotic burden and index of microcirculatory resistance (ATI score)

De Maria G, Fahrni G, Alkhalil M, Cuculi F, Dawkins S, Wolfrum M, Choudhury R, Forfar J, Prendergast B, Yetgin T, van Geuns R, Tebaldi M, Channon KM, Kharbanda R, Rothwell P, Valgimigli M, Banning A

November 20, 2016 | 10.4244/EIJV12I10A202

Coronary interventions

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

Vranckx P, Valgimigli M, Windecker S, Steg P, Hamm C, Jüni P, Garcia-Garcia H, Van Es G-A, Serruys P

November 20, 2016 | 10.4244/EIJY15M11_07

Latest news

NEW ISSUE

Challenging TAVI anatomies, risk prediction for PCI of CTOs, antithrombotic strategies, and more

April 3, 2020

JAA

NEW ahead of print: FFR and myocardial mass

Post atrioventricular (AV) branch intervention coronary angiogram

April 8, 2020

Editorial

CTO Percutaneous Coronary Intervention Scores: Present and Future

Evangelia Vemmou

April 8, 2020

Trials Book

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

Cardiocerebral Continuum in Cognitive Function After TAVI

Rodrigo Bagur

April 3, 2020

JAA

This week’s JAA’s: Coronary Bifurcation in Asia Pacific, 3year outcomes: Compare-ACUTE...

Marco Valgimigli

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke